IQVIA Holdings Inc. (IQV) stock
IQVNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 9/3013% above fair value
$245.82−4.73 (-1.89%)
Close on Nov 20, 2026Market cap $40.51BP/E 29.9Yield –
Iqvia net income
Net income is the profit left for shareholders after every expense, interest and tax.
Iqvia's net income for the twelve months ending Sep 30, 2026 was $1.39B, up 8.7% year over year. For fiscal 2025 it was $1.36B, down 0.9% from the year before. Over ten years it grew 13.4% a year on average. The highest annual figure on record is $1.37B in fiscal 2024.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.36B | -0.9% |
| FY2024 | Dec 31, 2024 | $1.37B | +1.1% |
| FY2023 | Dec 31, 2023 | $1.36B | +24.5% |
| FY2022 | Dec 31, 2022 | $1.09B | +12.9% |
| FY2021 | Dec 31, 2021 | $966.00M | +246.2% |
| FY2020 | Dec 31, 2020 | $279.00M | +46.1% |
| FY2019 | Dec 31, 2019 | $191.00M | -26.3% |
| FY2018 | Dec 31, 2018 | $259.00M | -79.7% |
| FY2017 | Dec 31, 2017 | $1.28B | +1673.6% |
| FY2016 | Dec 31, 2016 | $72.00M | -81.4% |
| FY2015 | Dec 31, 2015 | $387.00M | +8.4% |
| FY2014 | Dec 31, 2014 | $357.00M | +57.6% |
| FY2013 | Dec 31, 2013 | $226.59M | +27.6% |
| FY2012 | Dec 31, 2012 | $177.55M | -26.6% |
| FY2011 | Dec 31, 2011 | $241.77M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $350.00M | +5.7% |
| Q2 FY2026 | Jun 30, 2026 | $256.00M | -3.8% |
| Q1 FY2026 | Mar 31, 2026 | $274.00M | +10.0% |
| Q4 FY2025 | Dec 31, 2025 | $514.00M | +17.6% |
| Q3 FY2025 | Sep 30, 2025 | $331.00M | +16.1% |
| Q2 FY2025 | Jun 30, 2025 | $266.00M | -26.7% |
| Q1 FY2025 | Mar 31, 2025 | $249.00M | -13.5% |
| Q4 FY2024 | Dec 31, 2024 | $437.00M | -6.8% |
| Q3 FY2024 | Sep 30, 2024 | $285.00M | -5.9% |
| Q2 FY2024 | Jun 30, 2024 | $363.00M | +22.2% |
| Q1 FY2024 | Mar 31, 2024 | $288.00M | -0.3% |
| Q4 FY2023 | Dec 31, 2023 | $469.00M | +106.6% |
| Q3 FY2023 | Sep 30, 2023 | $303.00M | +7.1% |
| Q2 FY2023 | Jun 30, 2023 | $297.00M | +16.0% |
| Q1 FY2023 | Mar 31, 2023 | $289.00M | -11.1% |
| Q4 FY2022 | Dec 31, 2022 | $227.00M | -28.6% |
| Q3 FY2022 | Sep 30, 2022 | $283.00M | +8.4% |
| Q2 FY2022 | Jun 30, 2022 | $256.00M | +46.3% |
| Q1 FY2022 | Mar 31, 2022 | $325.00M | +53.3% |
| Q4 FY2021 | Dec 31, 2021 | $318.00M | +167.2% |
| Q3 FY2021 | Sep 30, 2021 | $261.00M | +158.4% |
| Q2 FY2021 | Jun 30, 2021 | $175.00M | – |
| Q1 FY2021 | Mar 31, 2021 | $212.00M | +158.5% |
| Q4 FY2020 | Dec 31, 2020 | $119.00M | +643.8% |
| Q3 FY2020 | Sep 30, 2020 | $101.00M | +77.2% |
| Q2 FY2020 | Jun 30, 2020 | -$23.00M | -138.3% |
| Q1 FY2020 | Mar 31, 2020 | $82.00M | +41.4% |
| Q4 FY2019 | Dec 31, 2019 | $16.00M | -76.8% |
| Q3 FY2019 | Sep 30, 2019 | $57.00M | -5.0% |
| Q2 FY2019 | Jun 30, 2019 | $60.00M | -1.6% |
| Q1 FY2019 | Mar 31, 2019 | $58.00M | -15.9% |
| Q4 FY2018 | Dec 31, 2018 | $69.00M | -93.3% |
| Q3 FY2018 | Sep 30, 2018 | $60.00M | -31.8% |
| Q2 FY2018 | Jun 30, 2018 | $61.00M | -1.6% |
| Q1 FY2018 | Mar 31, 2018 | $69.00M | -31.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.03B | – |
| Q3 FY2017 | Sep 30, 2017 | $88.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $62.00M | – |
| Q1 FY2017 | Mar 31, 2017 | $100.00M | – |
| Q4 FY2016 | Dec 31, 2016 | -$178.00M | – |
See a number that looks wrong?